This cross-sectional study characterizes the premarket clinical evidence supporting clearance of moderate-risk novel therapeutic medical devices by the US Food and Drug Administration.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551221 | PMC |
| http://dx.doi.org/10.1001/jamainternmed.2020.3214 | DOI Listing |
Publication Analysis
Top Keywords
clinical evidence
8
evidence supporting
8
food drug
8
drug administration
8
novel therapeutic
8
supporting food
4
administration clearance
4
clearance novel
4
therapeutic devices
4
devices novo
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!